Literature DB >> 24725415

SnapShot: cancer vaccines.

Karolina Palucka1, Jacques Banchereau2.   

Abstract

This SnapShot illustrates the main concepts and underlying biology of therapeutic vaccination in cancer. Dendritic cells (DCs) are an essential component of vaccination through their capacity to capture, process, and present antigens to T cells. We have come a long way in our understanding of what is needed to elicit therapeutic immunity when cancer escapes the natural barrier of protective immunity. This progress enables the development of novel vaccines.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24725415     DOI： 10.1016/j.cell.2014.03.044

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  10 in total

1.  Activation of Antigen-Specific CD8(+) T Cells by Poly-DL-Lactide/Glycolide (PLGA) Nanoparticle-Primed Gr-1(high) Cells.

Authors:  Wen-Hui Luo; Ya-Wun Yang
Journal:  Pharm Res       Date:  2015-12-29       Impact factor: 4.200

2.  Trial watch: Naked and vectored DNA-based anticancer vaccines.

Authors:  Norma Bloy; Aitziber Buqué; Fernando Aranda; Francesca Castoldi; Alexander Eggermont; Isabelle Cremer; Catherine Sautès-Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

3.  Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.

Authors:  Sachet A Shukla; Pavan Bachireddy; Bastian Schilling; Christina Galonska; Qian Zhan; Clyde Bango; Rupert Langer; Patrick C Lee; Daniel Gusenleitner; Derin B Keskin; Mehrtash Babadi; Arman Mohammad; Andreas Gnirke; Kendell Clement; Zachary J Cartun; Eliezer M Van Allen; Diana Miao; Ying Huang; Alexandra Snyder; Taha Merghoub; Jedd D Wolchok; Levi A Garraway; Alexander Meissner; Jeffrey S Weber; Nir Hacohen; Donna Neuberg; Patrick R Potts; George F Murphy; Christine G Lian; Dirk Schadendorf; F Stephen Hodi; Catherine J Wu
Journal:  Cell       Date:  2018-04-12       Impact factor: 41.582

Review 4.  Trial Watch: Immunotherapy plus radiation therapy for oncological indications.

Authors:  Erika Vacchelli; Norma Bloy; Fernando Aranda; Aitziber Buqué; Isabelle Cremer; Sandra Demaria; Alexander Eggermont; Silvia Chiara Formenti; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2016-07-25       Impact factor: 8.110

5.  Diversity and collaboration for effective immunotherapy.

Authors:  Karolina Palucka; Jacques Banchereau
Journal:  Nat Med       Date:  2016-12-06       Impact factor: 53.440

6.  Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses.

Authors:  Hua Li; Shengwen Shao; Jianshu Cai; Danielle Burner; Lingeng Lu; Qiuqiang Chen; Boris Minev; Wenxue Ma
Journal:  Immunology       Date:  2017-07-27       Impact factor: 7.397

Review 7.  Chemical tools to monitor and manipulate the adaptive immune system.

Authors:  Thomas Kodadek
Journal:  Chem Biol       Date:  2014-09-18

Review 8.  Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy.

Authors:  Elena García-Martínez; Melody Smith; Aitziber Buqué; Fernando Aranda; Francisco Ayala de la Peña; Alejandra Ivars; Manuel Sanchez Cánovas; Ma Angeles Vicente Conesa; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-02-15       Impact factor: 8.110

Review 9.  Tackling the tumor microenvironment: what challenge does it pose to anticancer therapies?

Authors:  Fei Chen; Xinyi Qi; Min Qian; Yue Dai; Yu Sun
Journal:  Protein Cell       Date:  2014-09-05       Impact factor: 14.870

10.  The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers.

Authors:  Viriya Kaewkangsadan; Chandan Verma; Jennifer M Eremin; Gerard Cowley; Mohammad Ilyas; Sukchai Satthaporn; Oleg Eremin
Journal:  J Immunol Res       Date:  2017-08-23       Impact factor: 4.818
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.